Governing Hospital Payment Integrity: False Claims, Kickbacks, Self-Referral, Medical Necessity, Overpayments, and Executive Assurance, a Narrative Review

Abstract

Hospital payment-integrity risk is often treated as a billing problem discovered after a claim is submitted. That framing is too narrow. The evidence that supports a lawful payment begins earlier, when a health system structures a physician arrangement, accepts a referral, makes a clinical decision, documents a service, assigns a code, releases a claim, interprets a payment, and responds to a credible signal of error. A failure at any one of those points can create an inaccurate claim, an overpayment, a patient-access problem, or potential exposure under the False Claims Act, Anti-Kickback Statute, physician self-referral law, and related Medicare requirements.

This narrative review integrates current federal statutes, regulations, controlling and illustrative federal decisions, agency guidance, and peer-reviewed evidence relevant to U.S. acute-care hospitals and health systems. It distinguishes five legal questions that are frequently collapsed into one: whether an arrangement is permissible, whether a referral is restricted, whether a service is clinically appropriate and covered, whether a claim is accurate and material, and whether a payment must be investigated and returned. The review proposes a Six-Record Integrity Ledger that connects the arrangement, referral, clinical, claim, payment, and resolution records. It assigns four executive decision rights: authorize the arrangement, release or hold the claim, investigate and quantify a payment signal, and refund or disclose and close the matter.

The central finding is that effective assurance depends less on adding another retrospective audit than on preserving contemporaneous evidence across organizational boundaries. Compliance guidance can inform that system, but it does not replace the elements of the governing law or fact-specific legal analysis. Hospitals should build controls that protect truthful billing without deterring legitimate physician alignment, clinically appropriate care, or emergency access. This review is not a 50-state survey and does not provide legal advice.

Keywords: hospital payment integrity; False Claims Act; Anti-Kickback Statute; Stark Law; medical necessity; overpayments; physician compensation; compliance; executive assurance

Introduction: the claim begins before billing

A hospital claim is not simply an invoice. It is the final representation produced by a chain of clinical, contractual, operational, and financial decisions. The chain may begin with a physician employment agreement, medical-director contract, recruitment package, equipment lease, laboratory relationship, service-line joint venture, or vendor incentive. It continues through the referral or order, the clinical record, utilization review, coding, charge capture, claim edits, submission, payment, denial, credit balance, audit, and refund process. The claim is therefore the last visible step in a much larger governance system.

The enforcement environment makes this distinction consequential. The U.S. Department of Justice reported more than $6.8 billion in False Claims Act settlements and judgments for fiscal year 2025, including more than $5.7 billion involving the health care industry. It also reported a record 1,297 qui tam filings. DOJ identified managed care, prescription drugs, and medically unnecessary care as three major areas of continued and expanded health care enforcement [14]. These figures describe enforcement activity, not the prevalence of fraud, and settlements are not holdings or admissions unless their terms say otherwise. They do show that payment representations remain a central point of federal scrutiny.

Hospital leaders face two symmetrical errors. The first is underreaction: treating an arrangement, documentation defect, or recurring credit as an isolated operational issue until it has affected a large claim population. The second is overreaction: equating every denial, documentation disagreement, coding change, or overpayment with fraud. The False Claims Act does not convert ordinary error into fraud. Liability turns on the elements applicable to the asserted theory, including falsity and knowledge and, where applicable, materiality and causation [1,3,4]. Likewise, an arrangement outside an Anti-Kickback Statute safe harbor is not automatically unlawful, and a Stark exception does not immunize an arrangement under other laws [5-8].

The executive task is to build a system that can tell the difference. That system must preserve evidence while decisions are being made, identify patterns without substituting analytics for judgment, protect employees who raise concerns, and move promptly when a credible signal suggests that payments may be wrong. It must also keep payment controls from interfering with emergency screening, stabilization, medically appropriate care, or patient choice.

This review frames payment integrity as an enterprise operating model rather than a compliance-department project. Its organizing thesis is simple: if a hospital cannot connect the business purpose, referral safeguards, clinical basis, claim representation, payment outcome, and resolution decision, it cannot provide reliable executive assurance.

Methods and authority hierarchy

This single-author narrative review used separate legal and empirical searches completed through August 14, 2026. The legal search reviewed the current U.S. Code, electronic Code of Federal Regulations, U.S. Supreme Court decisions, selected federal appellate decisions, and official materials from the Centers for Medicare & Medicaid Services, HHS Office of Inspector General, and Department of Justice. Priority was given to binding statutes and regulations, then controlling case law, then persuasive case law and nonbinding agency guidance. Enforcement announcements were used only as labeled context.

The empirical search used PubMed and targeted citation tracing. Search concepts included hospital or health system with false claims, health care fraud, upcoding, clinical coding, physician self-referral, medical necessity, whistleblowing, speaking up, and audit feedback. English-language peer-reviewed original studies and systematic reviews relevant to U.S. hospitals were prioritized. Studies from other health systems were included only when they addressed generalizable documentation, coding, or organizational behavior. Legal commentary, news, blogs, vendor reports, and unsupported opinion were excluded as evidence.

This was a purposive, reproducible narrative search, not a systematic review or meta-analysis. One author screened and interpreted sources. No formal risk-of-bias tool was applied, and no pooled effect was calculated. The review does not resolve state-law requirements, payer-specific contract terms, or every federal exception and safe harbor. Those issues require current, jurisdiction-specific advice from qualified counsel.

One payment, five different legal questions

The phrase payment integrity can conceal distinct legal questions. Separating them is the first control.

Arrangement and referral risk: governance before the claim

Hospitals increasingly organize care through employment, affiliations, co-management, service-line ventures, telehealth, laboratory and pharmacy relationships, managed-care delegation, and vendor-supported programs. These structures can improve access, coordination, quality, and continuity. They can also create financial incentives that affect where patients are sent, which products are selected, and how services are documented or billed.

Peer-reviewed evidence supports treating these incentives as governance signals, not legal conclusions. In a national Medicare study, hospital ownership of physician practices substantially increased the probability that patients used the owning hospital; the authors also found increased selection of high-cost, low-quality hospitals in some circumstances [24]. Another study found that vertical integration shifted common imaging and laboratory services toward hospital settings and higher Medicare reimbursement [25]. Earlier work on imaging self-referral found higher utilization and episode costs in many examined conditions [26,27]. These associations do not establish remuneration, unlawful intent, a restricted referral, or a false claim. They show why referral independence, patient choice, compensation design, and utilization patterns require monitoring.

A defensible arrangement process should answer five questions before signature:

1. What patient-care or operational need does the arrangement solve?
2. What services, resources, and performance are actually required?
3. How was compensation or other economic value determined?
4. Which Stark exception, Anti-Kickback Statute safe harbor, advisory analysis, or other legal rationale applies?
5. What facts would require reapproval, suspension, or termination?

The monitoring process should then compare the agreement with performance. Timesheets, deliverables, scheduling data, call logs, meeting records, compensation changes, ownership changes, referral patterns, utilization, and patient-choice documentation may all be relevant. A contract that was defensible when executed can become problematic if services are not performed, compensation drifts, the business structure changes, or operational practice no longer matches the approved facts.

The Fourth Circuit's fact-specific, pre-Escobar Tuomey decision remains an important hospital example because it linked physician compensation, referral value, Stark analysis, and False Claims Act scienter [28]. It should not be reduced to a slogan that all productivity compensation is unlawful. Its governance lesson is narrower and more useful: decision-makers must test the actual economic arrangement, heed credible legal warnings, and document how disputed issues were resolved.

The Fourth Circuit's 2026 Kyer decision distinguishes Tuomey. It held that work relative value unit compensation based on a physician's personally performed services does not take referrals into account merely because more hospital work correlates with more hospital revenue. Referral volume or value must enter the compensation formula as a variable. Conclusory labels, high compensation, health-system subsidies, or claim tables do not by themselves plausibly plead Stark- or Anti-Kickback Statute-based False Claims Act claims [41].

Medical necessity: protect judgment and test the representation

Medical-necessity controls can fail in opposite directions. Weak controls may allow orders, admissions, procedures, or recurring services that lack support. Aggressive utilization controls may pressure clinicians, second-guess reasonable uncertainty, or delay care. A mature program protects both clinical independence and truthful payment representations.

Three records should be reviewed together but assessed separately:

• Clinical basis: the patient's condition, alternatives, risks, expected benefit, and the clinician's contemporaneous reasoning.
• Coverage basis: the benefit category, national or local coverage rule, payer policy, authorization, frequency limit, and other payment conditions.
• Claim support: the order, certification, note, code, modifier, units, place of service, and any attestation submitted or implied.

The distinction is visible in current empirical research. A 2026 study of 4.2 million Traditional Medicare sepsis hospitalizations found that 22.6% of stays assigned a sepsis diagnosis-related group lacked a coded acute organ dysfunction and were classified by the investigators as discordant with Sepsis-3. These stays had markedly lower mortality and were associated with an estimated $114 million in higher annual payments compared with alternative infection classifications [21]. The study did not determine fraud, clinician intent, or legal falsity. It illustrates how a gap between clinical definitions, coding rules, and payment categories can produce both financial and quality-measure consequences.

Coding-intensity studies present the same caution. Crespin and colleagues estimated that changes in coding behavior could explain up to two-thirds of the growth in highest-intensity discharges across five states from 2011 to 2019, with large associated payments [20]. Silverman and Skinner found different pneumonia coding patterns by hospital ownership in earlier Medicare data [22]. In Medicare Advantage, Jacobs and Layton estimated materially higher risk scores after beneficiaries switched from Traditional Medicare, consistent with coding-intensity effects [23]. None of these studies proves that a specific claim was false. They show that payment systems create incentives and that aggregate outliers deserve disciplined review.

Controls should therefore begin with targeted, clinically credible questions. Is a diagnosis being documented because it affected care, or because it increases reimbursement? Does the record support the severity level? Are queries nonleading? Do outlier clinicians, service lines, vendors, or coders receive independent review? Are quality metrics, risk scores, and payment categories changing in parallel without a plausible patient-mix explanation?

Intervention evidence suggests that accuracy can improve without assuming misconduct. Targeted education for clinicians and coders reduced the proportion of records requiring coding changes in a single-ward quality-improvement project [29]. A U.S. specialty-clinic study found that repeated feedback improved evaluation-and-management coding accuracy [30]. These are limited, context-specific studies, but they support a learning system that uses audit findings to clarify documentation and coding rather than simply recover dollars.

Claim accuracy and the False Claims Act nexus

A hospital's claim-production system crosses departmental boundaries. Clinicians document; utilization teams apply status and coverage rules; coders translate records; revenue-cycle systems generate charges; compliance and audit teams test patterns; finance posts payments and credits; and legal counsel interprets uncertain requirements. No single function sees the whole representation.

This fragmentation creates predictable failure modes:

• a physician arrangement is approved, but its referral or compensation safeguards are not communicated to operations;
• a clinical documentation query changes a diagnosis without a corresponding change in clinical reasoning;
• an edit is overridden repeatedly with no record of who approved the override;
• a denial trend is treated as payer behavior even when it signals a recurring source defect;
• an internal audit identifies errors in a sample, but related claims are not assessed;
• a credit balance remains unresolved because ownership is split across finance and revenue cycle;
• a vendor controls ordering, coding, or documentation logic without independent validation;
• a legal interpretation is stored in email but not translated into claim edits, education, or monitoring.

The control objective is claim provenance: the hospital should be able to reconstruct the material facts and decisions supporting a claim without relying on personal memory. Provenance is not a demand for perfect documentation. It is a reliable link from the service and arrangement to the representation made to the payer.

Escalation should be driven by risk, not merely dollar value. Relevant factors include patient harm, deliberate conduct, leadership involvement, the number and age of claims, recurrence, prior warnings, concealment, retaliation, effect on federal programs, and whether claims continue while the issue remains unresolved. A small dollar issue can be material if it reveals intentional conduct or broad system failure. A large statistical anomaly may be explainable and lawful. Analytics identify where to ask questions; they do not decide falsity or intent.

After payment: identification, investigation, and return

Hospitals receive payment signals from many sources: denials, payer audits, employee reports, hotline calls, physician concerns, vendor notices, government inquiries, coding reviews, credit balances, patient complaints, litigation holds, data analytics, and acquired-entity diligence. The first governance question is whether the signal is credible enough to require action. The second is who has authority to stop further claims, preserve evidence, and define the investigation.

A reliable response has six stages.

The Six-Record Integrity Ledger

The proposed Six-Record Integrity Ledger is an evidence-informed assurance framework, not a new legal standard or a validated anti-fraud intervention. It connects the evidence already produced by contracting, operations, clinical care, revenue cycle, finance, compliance, and legal functions. Each record has an accountable owner, minimum evidence, a release or hold decision, and an escalation threshold.

Executive operating model and board assurance

HHS OIG's General Compliance Program Guidance describes seven familiar elements, including written standards, compliance leadership, training, communication, enforcement, auditing, and response. OIG expressly identifies the guidance as voluntary and nonbinding [11]. DOJ Criminal Division's September 2024 Evaluation of Corporate Compliance Programs asks whether a program is well designed, adequately resourced and empowered, and effective in practice. DOJ's March 10, 2026 Department-wide Corporate Enforcement and Voluntary Self-Disclosure Policy separately addresses corporate criminal self-disclosure, cooperation, and remediation [12,13]. These are prosecutorial policy materials, not health care payment rules, False Claims Act safe harbors, or substitutes for OIG and CMS disclosure processes.

For payment integrity, effectiveness can be tested through concrete evidence:

• Does compliance have independent access to the board and authority to obtain data?
• Can the organization identify all active physician and referral-sensitive arrangements?
• Are legal assumptions translated into operational controls and monitoring rules?
• Are coding, utilization, and referral outliers reviewed by qualified, independent personnel?
• Can a credible signal trigger a targeted claim hold without revenue-owner approval?
• Are investigation dates, affected populations, refund decisions, and remediation recorded?
• Are employees protected from retaliation, including subtle changes in duties or performance expectations?
• Does compensation reward compliant performance and impose consequences for misconduct or supervisory failure?
• Are acquired entities, vendors, laboratories, and delegated partners included in risk assessment and monitoring?
• Does the board receive leading indicators, overdue actions, and unresolved disagreements rather than only training completion and audit counts?

Whistleblower evidence reinforces the importance of credible internal channels. In a qualitative study of 26 relators in successful pharmaceutical fraud cases, most insiders first tried to raise concerns internally, and many described serious professional, financial, and health consequences [31]. The study is small and not hospital specific, but it challenges the assumption that financial awards are the primary reason employees report. A 2024 systematic review of 45 hospital speaking-up studies found interacting individual, relational, contextual, and organizational influences [32]. Reporting systems therefore require more than a hotline. They need responsive leaders, anti-retaliation monitoring, feedback, fair investigation, and evidence that raising a concern can change a decision.

Board reporting should focus on the integrity system rather than active-case details that would impair privilege or confidentiality. Useful measures include arrangement re-reviews completed on time, unsupported performance records, high-risk claim overrides, repeat coding findings, unresolved credit balances, days from credible signal to triage, good-faith investigations approaching 180 days, refund timeliness, recurrence testing, substantiated retaliation, and overdue corrective actions. Trend and concentration matter more than a single target number.

Disclosure, remediation, and patient-access safeguards

Payment integrity must not become a reason to withhold necessary care or discourage clinicians from documenting legitimate acuity. Controls should state that emergency screening and stabilization obligations remain independent of ability to pay, prior authorization, network status, or retrospective payment concerns. For EMTALA-required items and services, Medicare reasonable-and-necessary determinations must be based on information available to the treating physician or practitioner when the service was ordered or furnished, including the presenting symptoms or complaint, and not on the patient's principal diagnosis [15].

Likewise, physician alignment and value-based care are not inherently suspect. Federal regulations include exceptions and safe harbors designed for qualifying arrangements. The governance task is to ensure that the facts, documentation, and safeguards match the pathway being used. Patient choice, access, quality, and equity should be monitored alongside utilization and payment.

When an issue is substantiated, remediation should reach the source. Possible actions include contract amendment or termination, compensation correction, claim edits, clinical and coding education, vendor controls, access redesign, personnel accountability, enhanced monitoring, repayment, and disclosure. Counsel should direct decisions involving privilege, government contact, sampling, and state or contractual obligations.

Limitations

This review is narrative and purposive. It did not search every legal database, payer rule, or clinical specialty, and one author performed screening. No formal study-quality instrument or pooled analysis was used. Several empirical studies were observational, used administrative claims, or arose outside U.S. hospitals; association does not establish legal falsity, intent, causation, or materiality. Medical-necessity and Anti-Kickback Statute causation standards vary among federal circuits. This is not a 50-state survey. State false-claims, anti-kickback, self-referral, fee-splitting, corporate-practice, Medicaid, and commercial-payer rules may be broader than federal law. Authorities and enforcement policies should be refreshed immediately before publication and applied with local counsel.

Conclusion

The claim is the last step, not the beginning, of hospital payment integrity. A health system cannot assure truthful reimbursement by auditing codes alone. It must connect the arrangement, referral, clinical judgment, claim, payment, and resolution evidence that produced the claim and its final disposition.

The Six-Record Integrity Ledger gives boards and executives a practical way to assign ownership and decision rights without collapsing every defect into fraud. It protects two obligations at once: the duty to submit and retain only supportable payments, and the duty to preserve legitimate clinical judgment, physician alignment, patient choice, and access to care. The decisive measure is not whether the organization has a compliance program on paper. It is whether the organization can show, contemporaneously and credibly, why it authorized, billed, investigated, refunded, and closed.

Acknowledgments

The author thanks the clinicians, compliance professionals, revenue-cycle leaders, legal counsel, auditors, and patient advocates whose work informs practical payment-integrity governance.

Publication statements

Funding: No external funding was received for this review.

Conflicts of interest: The author declares no conflict of interest.

Ethics review: Not applicable. This article did not involve human participants or identifiable patient data.

Data sharing: No new dataset was created. All sources are publicly available through the cited publications and official authorities.

Disclaimer: This article is for executive education. It is not legal, regulatory, clinical, reimbursement, labor, accounting, insurance, or investment advice. Organizations should obtain fact-specific advice from qualified counsel and applicable clinical, coding, compliance, and financial experts.

References

1. 31 U.S.C. § 3729. False claims. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title31-section3729
2. 31 U.S.C. § 3730. Civil actions for false claims. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title31-section3730
3. Universal Health Services, Inc. v. United States ex rel. Escobar, 579 U.S. 176 (2016). https://www.govinfo.gov/app/details/USREPORTS-579/USREPORTS-579-176
4. United States ex rel. Schutte v. SuperValu Inc., 598 U.S. 739 (2023). https://www.supremecourt.gov/opinions/22pdf/21-1326_6jfl.pdf
5. 42 U.S.C. § 1320a-7b(b), (g). Criminal penalties for acts involving Federal health care programs. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1320a-7b
6. 42 C.F.R. § 1001.952. Exceptions and Anti-Kickback Statute safe harbors. https://www.ecfr.gov/current/title-42/chapter-V/subchapter-B/part-1001/subpart-C/section-1001.952
7. 42 U.S.C. § 1395nn. Limitation on certain physician referrals. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1395nn
8. 42 C.F.R. §§ 411.350-411.389. Financial relationships between physicians and entities furnishing designated health services. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-411/subpart-J
9. 42 U.S.C. § 1320a-7k(d). Reporting and returning of overpayments. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1320a-7k
10. 42 C.F.R. § 401.305. Requirements for reporting and returning of overpayments. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-A/part-401/subpart-D/section-401.305
11. U.S. Department of Health and Human Services, Office of Inspector General. General Compliance Program Guidance. November 2023. https://oig.hhs.gov/compliance/general-compliance-program-guidance/
12. U.S. Department of Justice, Criminal Division. Evaluation of Corporate Compliance Programs. September 2024. https://www.justice.gov/criminal/criminal-fraud/page/file/937501
13. U.S. Department of Justice. Department-wide Corporate Enforcement and Voluntary Self-Disclosure Policy. March 10, 2026. https://www.justice.gov/criminal/corporate-enforcement
14. U.S. Department of Justice. False Claims Act settlements and judgments exceed $6.8 billion in fiscal year 2025. January 16, 2026. https://www.justice.gov/opa/pr/false-claims-act-settlements-and-judgments-exceed-68b-fiscal-year-2025
15. 42 U.S.C. § 1395y(a)(1)(A), (d); Centers for Medicare & Medicaid Services. Medical review and education. https://www.cms.gov/data-research/monitoring-programs/medicare-fee-service-compliance-programs/medical-review-and-education
16. U.S. Department of Health and Human Services, Office of Inspector General. General questions regarding certain fraud and abuse authorities. https://oig.hhs.gov/faqs/general-questions-regarding-certain-fraud-and-abuse-authorities/
17. Centers for Medicare & Medicaid Services. Physician self-referral. https://www.cms.gov/medicare/regulations-guidance/physician-self-referral
18. U.S. Department of Health and Human Services, Office of Inspector General. Health Care Fraud Self-Disclosure Protocol. https://oig.hhs.gov/compliance/self-disclosure-info/self-disclosure-protocol/
19. Centers for Medicare & Medicaid Services. Voluntary Self-Referral Disclosure Protocol. https://www.cms.gov/medicare/regulations-guidance/physician-self-referral/self-referral-disclosure-protocol
20. Crespin D, Dworsky M, Levin J, Ruder T, Whaley CM. Upcoding linked to up to two-thirds of growth in highest-intensity hospital discharges in 5 states, 2011-19. Health Affairs. 2024;43(12):1619-1627. doi:10.1377/hlthaff.2024.00596.
21. Ryan AM, Prescott HC, Lin Y, Rooke-Ley H, Buxbaum JD. The association between sepsis coding and payment to U.S. hospitals. Health Services Research. 2026;61(3):e70135. doi:10.1111/1475-6773.70135.
22. Silverman E, Skinner J. Medicare upcoding and hospital ownership. Journal of Health Economics. 2004;23(2):369-389. doi:10.1016/j.jhealeco.2003.09.007.
23. Jacobs PD, Layton TJ. Identifying coding intensity in Medicare Advantage through switchers. Health Services Research. 2025;60(5):e14628. doi:10.1111/1475-6773.14628.
24. Baker LC, Bundorf MK, Kessler DP. The effect of hospital/physician integration on hospital choice. Journal of Health Economics. 2016;50:1-8. doi:10.1016/j.jhealeco.2016.08.006.
25. Whaley CM, Zhao X, Richards M, Damberg CL. Higher Medicare spending on imaging and lab services after primary care physician group vertical integration. Health Affairs. 2021;40(5):702-709. doi:10.1377/hlthaff.2020.01006.
26. Hughes DR, Bhargavan M, Sunshine JH. Imaging self-referral associated with higher costs and limited impact on duration of illness. Health Affairs. 2010;29(12):2244-2251. doi:10.1377/hlthaff.2010.0413.
27. Levin DC, Rao VM. The effect of self-referral on utilization of advanced diagnostic imaging. AJR American Journal of Roentgenology. 2011;196(4):848-852. doi:10.2214/AJR.10.5823.
28. United States ex rel. Drakeford v. Tuomey Healthcare System, Inc., 792 F.3d 364 (4th Cir. 2015). https://www.govinfo.gov/content/pkg/USCOURTS-ca4-13-02219/pdf/USCOURTS-ca4-13-02219-0.pdf
29. Radhakrishnan ST, Perry R, Misra S, Ray S, Ruban A, Quayson BI, Fofaria R, Hudovsky A, Williams HRT. Targeted education for clinicians and clinical coding staff improves the accuracy of clinical coding: a quality improvement project. Future Healthcare Journal. 2024;11(1):100127. doi:10.7861/fhj.2023-0021.
30. Gill AS, Menjivar D, Shipman P, Sumsion J, Error M, Alt JA. Healthcare provider feedback improves outpatient E/M billing and coding in otolaryngology clinics. OTO Open. 2023;7(1):e20. doi:10.1002/oto2.20.
31. Kesselheim AS, Studdert DM, Mello MM. Whistle-blowers' experiences in fraud litigation against pharmaceutical companies. New England Journal of Medicine. 2010;362(19):1832-1839. doi:10.1056/NEJMsr0912039.
32. van Dongen D, Guldenmund F, Grossmann I, Groeneweg J. Classification of influencing factors of speaking-up behaviour in hospitals: a systematic review. BMC Health Services Research. 2024;24:1657. doi:10.1186/s12913-024-12138-x.
33. United States v. Regeneron Pharmaceuticals, Inc., 128 F.4th 324 (1st Cir. 2025). https://www.ca1.uscourts.gov/sites/ca1/files/opnfiles/23-2086P-01A.pdf
34. United States ex rel. Greenfield v. Medco Health Solutions, Inc., 880 F.3d 89 (3d Cir. 2018). https://www2.ca3.uscourts.gov/opinarch/171152p.pdf
35. United States ex rel. Flanagan v. Fresenius Medical Care Holdings, Inc., No. 23-1305 (1st Cir. June 27, 2025). https://www.ca1.uscourts.gov/sites/ca1/files/opnfiles/23-1305P-01A.pdf
36. United States v. AseraCare Inc., 938 F.3d 1278 (11th Cir. 2019). https://media.ca11.uscourts.gov/opinions/pub/files/201613004.pdf
37. United States ex rel. Druding v. Care Alternatives, 952 F.3d 89 (3d Cir. 2020), and 81 F.4th 361 (3d Cir. 2023). https://www2.ca3.uscourts.gov/opinarch/183298p.pdf
38. Winter ex rel. United States v. Gardens Regional Hospital & Medical Center, Inc., 953 F.3d 1108 (9th Cir. 2020). https://cdn.ca9.uscourts.gov/datastore/opinions/2020/03/23/18-55020.pdf
39. United States ex rel. Polukoff v. St. Mark's Hospital, 895 F.3d 730 (10th Cir. 2018). https://www.ca10.uscourts.gov/sites/ca10/files/opinions/010110019400.pdf
40. United States ex rel. Omni Healthcare Inc. v. MD Spine Solutions LLC, No. 25-1110 (1st Cir. Dec. 1, 2025). https://www.ca1.uscourts.gov/sites/ca1/files/opnfiles/25-1110P-01A.pdf
41. United States ex rel. Kyer v. Thomas Health System, Inc., No. 25-1507 (4th Cir. June 4, 2026). https://www.ca4.uscourts.gov/opinions/251507.P.pdf